Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE007 (JPN) (Dr. Dubois)
· consented 2023-04-08
Adverse events
4
Serious AEs
2
Open data queries
0
Luna dropout signal
–
Adverse events
severe
serious
assessed
2026-08-18
Grade 3 Pruritus — outcome: RECOVERED/RESOLVED; onset 2023-06-04 (study day 52); relationship: not assessed; serious criteria: hospitalization
mild
assessed
2026-08-18
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-09-12 (study day 152); relationship: not assessed
severe
serious
assessed
2026-08-18
Grade 3 Nausea — outcome: RECOVERED/RESOLVED; onset 2024-04-21 (study day 374); relationship: not assessed; serious criteria: hospitalization
moderate
assessed
2026-08-18
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2024-06-30 (study day 444); relationship: not assessed
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.